Neuroepidemiology is an important field that deserves critical attention globally and more specifically on the African continent. The African continent currently has less than adequate and reliable data on mental health generally or neurological disorders. Only few prevalence and incidence studies’ reports are available. Africa is affected by diverse neurological problems that deserve epidemiological attention ranging from chronic neurological disorders to outbreaks of epidemics of neurological importance, including konzo, lead poisoning, and infectious diseases of neurological importance. The current effort is an attempt to report perspectives about neuroepidemiology from Africa and to critically appraise the current scenarios toward deciphering the factors that have limited the development and advancements of the field in Africa. This article highlights specific points on needs as found and provides suggestions and recommendations on the way forward. The study was conducted in Nigeria through a network named ANDEN. Questionnaires were administered through all neuroscience-related platforms. Ninety-two respondents completed the questionnaires properly. Most respondents were young scientists with bachelors’ and master’s level of training and were almost equally divided between males and females. Their responses were analysed and presented as descriptive statistics and thematic summary of free responses. The interest of these African neuroscientists in neuroepidemiology ranked between high and very high. A good proportion rated the likelihood of a career path in neuroepidemiology between high and very high. The importance and relevance of the field to the advancement of mental health was also rated very high. The current attention and commitment of research efforts and funding to neuroepidemiology was, however, rated low. Many potential African neuroscientists would agree that their current greatest need is the knowledge of the subject and field of neuroepidemiology. By implication, there is a great need for them to be educated in this area. The findings showed that neuroepidemiology is a relatively neglected aspect of neurology and neuroscience research on the continent. The interest of respondents in this field underscores the critical and urgent need to develop the field, promote training and research funding toward developing capacities, and carrying out cutting edge research.

1.
Fiest
KM
,
Pringsheim
T
,
Patten
SB
,
Svenson
LW
,
Jetté
N
.
The role of systematic reviews and meta-analyses of incidence and prevalence studies in neuroepidemiology
.
Neuroepidemiology
.
2014
;
42
(
1
):
16
24
. .
2.
Kurtzke
JF
.
An introduction to neuroepidemiology
.
Neurol Clin
.
1996
;
14
(
2
):
255
72
. .
3.
Wallin
MT
,
Tornatore
C
.
John F Kurtzke, MD. FACP, FAAN (1926–2015)
.
Neurology
.
2016 Mar
;
86
(
12
):
1084
5
.
4.
Feigin
V
,
Kurtzke
JF
,
Korczyn
A
,
Beghi
E
,
Brown
A
.
Bridging the gap between experimental and non-experimental neuroepidemiology, and ultimately: between neuroepidemiological research and practice: round table discussion at the first international congress on clinical neurology and epidemiology
.
Neuroepidemiology
.
2009
;
33
(
4
):
296
304
.
5.
Ogunniyi
A
.
Neuroepidemiology in Africa
.
J Neurol Sci
.
2015
;
357
:
e494
512
. .
6.
Tsang
S
,
Royse
CF
,
Terkawi
AS
.
Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine
.
Saudi J Anaesth
.
2017
;
11
(
Suppl 1
):
S80
9
. .
7.
Feigin
V
,
Brainin
M
,
Breteler
MM
,
Martyn
C
,
Wolfe
C
,
Bornstein
N
, et al.
Teaching of neuroepidemiology in Europe: time for action
.
Eur J Neurol
.
2004
;
11
(
12
):
795
9
. .
8.
Mensah
GA
,
Sacco
RL
,
Vickrey
BG
,
Sampson
UK
,
Waddy
S
,
Ovbiagele
B
, et al.
From data to action: neuroepidemiology informs implementation research for global stroke prevention and treatment
.
Neuroepidemiology
.
2015
;
45
(
3
):
221
9
. .
9.
Preux
PM
,
Ratsimbazafy
V
,
Bhalla
D
,
Ngoungou
E
,
Quet
F
,
Druet-Cabanac
M
.
Méthodologie des études neuroépidémiologiques dans les pays tropicaux : un challenge ? [Methodology of neuroepidemiological studies in tropical countries: a challenge?]
.
Rev Neurol
.
2012
;
168
(
3
):
211
5
.
10.
Gourie-Devi
M
.
Relevance of neuroepidemiology: burden of neurological disorders and public health issues
.
Ann Indian Acad Neurol
.
2018 Oct–Dec
;
21
(
4
):
237
8
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.